$75.3 Million is the total value of Invenire Partners, LP's 29 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was - .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
New | Edgio Inc | $1,998,150,000 | – | 865,000 | +100.0% | 2.65% | – | |
CYRX | New | Cryoport Inc | $1,402,867,000 | – | 45,283 | +100.0% | 1.86% | – |
INVE | New | Identiv Inc | $1,379,675,000 | – | 119,143 | +100.0% | 1.83% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-15
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
DHI Group Inc | 4 | Q3 2022 | 7.9% |
Tetra Technologies Inc | 4 | Q3 2022 | 6.5% |
Harrow Health Inc | 4 | Q3 2022 | 8.4% |
TTEC Holdings Inc | 4 | Q3 2022 | 5.9% |
Clarus Corp | 4 | Q3 2022 | 5.9% |
Apyx Medical Corp | 4 | Q3 2022 | 6.5% |
InfuSystem Holdings Inc | 4 | Q3 2022 | 5.1% |
PAR Technology Corp | 4 | Q3 2022 | 4.9% |
Cantaloupe Inc | 4 | Q3 2022 | 5.2% |
Marcus Corp | 4 | Q3 2022 | 4.4% |
View Invenire Partners, LP's complete holdings history.
Latest filings
Type | Filed |
---|---|
SC 13G/A | 2023-03-31 |
SC 13G | 2023-01-23 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
13F-HR | 2022-05-13 |
13F-HR | 2022-02-14 |
D/A | 2019-03-12 |
D | 2018-01-02 |
View Invenire Partners, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.